Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ RFP Tag (aa 22-36) Synthetic Peptide

Synthetic Peptide

Supplier:  Invitrogen™ PEP260

Catalog No. ABC260


Add to Cart

Description

Description

RFP tag (residues 22-36) Synthetic Peptide, PEP-260, from Invitrogen.

PEP-260 is a 15 amino acid synthetic peptide whose sequence is derived from the RFP tag protein. The sequence of this peptide is (amino to carboxy terminus): V (22)-N-G-H-E-F-E-I-E-G-E-G-E-G-R (36)This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product, RFP Epitope Tag, catalog # PA1-986. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (∼70-fold) for competitive inhibition of antibody-protein binding reactions.Reconstitute with 0.1 ml of distilled water.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Non-species Specific
RFP Tag (aa 22-36)
-20°C. Avoid freeze-thaw cycles.
Lyophilized
Control
No preservative
50 μg
V(22) - N - G - H - E - F - E - I - E - G - E - G - E - G - R (36)
purified
0.5 mg/mL
Synthetic Peptide
peptide with no preservative
Yes
Peptide
RUO - research use only
Product Suggestions

Product Suggestions

Safety and Handling

Safety and Handling

WARNING: Reproductive Harm - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit